Reductive metabolism and activation of benznidazole.
Benznidazole (Bz) (N-benzyl-2-nitro-1-imidazole-acetamide) is a drug used against Chagas' disease. Rat liver microsomal and cytosolic fractions, but not mitochondria, exhibited Bz nitroreductase activity under anaerobic conditions in the presence of NADPH. Microsomal nitroreductase activity was enhanced by FAD and was inhibited totally by oxygen and partially by carbon monoxide. Liver cystosol fraction was able to reduce Bz nitrogroups in the presence of either N-methylnicotinamide or hypoxanthine as substrates. These enzyme activities were inhibited by menadione or allopurinol respectively. Under every experimental condition leading to enzymatic reduction of Bz nitrogroups and its inhibition or enhancement, reactive metabolites that bind covalently to proteins were also produced. This covalent binding was effectively prevented by reduced glutathione. Results suggest the participation of cytochrome P-450 and cytochrome c reductase in liver microsomal processes and of xanthine oxidase and aldehyde oxidase in liver cytosolic processes of Bz nitroreduction and activation to reactive metabolites that bind covalently to proteins. Possible pharmacological and toxicological implications of the described observations were discussed.
D000818:Animals; D001711:Biotransformation; D003600:Cytosol / Q000201:enzymology; D005182:Flavin-Adenine Dinucleotide / Q000494:pharmacology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009593:Nitroimidazoles / Q000378:metabolism*; D010084:Oxidation-Reduction; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains; D014344:Trypanocidal Agents / Q000378:metabolism*
D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D005182:Flavin-Adenine Dinucleotide; C009999:benzonidazole